CCPA passes order for discontinuation of Sensodyne ads in India

Consumer protection regulator CCPA has passed an order against GlaxoSmithKline Consumer Healthcare Ltd directing it to discontinue advertisements of Sensodyne products in India for flouting norms.

Sensodyne, advertisement,
In a new campaign, the company presents the brand as a matter of choice, not the outcome of a doctor’s prescription
Press Trust of India New Delhi
3 min read Last Updated : Feb 10 2022 | 1:44 AM IST

Consumer protection regulator CCPA has passed an order against GlaxoSmithKline (GSK) Consumer Healthcare Ltd directing it to discontinue advertisements of Sensodyne products in India for flouting norms.

The Central Consumer Protection Authority (CCPA) has also passed an order against Naaptol Online Shopping Ltd for misleading advertisements and unfair trade practice, and asked it pay a penalty of Rs 10 lakh.

CCPA took suo-moto cognizance of the matter and passed an order against GlaxoSmithKline (GSK) Consumer Healthcare on January 27, and against Naaptol on February 2 this year, the consumer affairs ministry said in a statement on Wednesday.

As per the order, the CCPA has directed GlaxoSmithKline (GSK) Consumer Healthcare to discontinue all advertisements for Sensodyne in the country within seven days of the issuance of the order as the ads showed dentists practicing outside India endorsing the products.

Given that the regulations governing dentists in India clearly bar endorsement of any product or drug publicly, the CCPA said GSK Consumer Healthcare "cannot be allowed to circumvent the law in force in India and show foreign dentists to exploit consumer apprehension towards tooth sensitivity."

"Therefore, advertisement of Sensodyne products in India which show endorsements by dentists practising outside India qualify as 'misleading advertisement' in terms of Section 2 (28) of the Consumer Protection Act, 2019," the order said.

The CCPA has also directed Director General (Investigation) to submit a report within 15 days after probing the claims "Recommended by dentists worldwide", "world's no.1 sensitivity toothpaste" and "clinically proven relief, works in 60 seconds" and the documents submitted by the company in support of these claims.

Taking up another suo-moto case, the CCPA passed an order against Naaptol Online Shopping Ltd asking the company to discontinue misleading advertisements of "Set of 2 Gold Jewelry", "Magnetic Knee Support" and "Acupressure Yoga Slippers".

The CCPA has also imposed a penalty of Rs 10 lakh on Naaptol, saying its misleading advertisements have had a far reaching impact on numerous consumers as the company runs a 24X7 channel and is broadcast on a daily basis across the country in various languages.

Naaptol was directed to clearly mention in the episodes offering products for sale to consumers that it is a recorded episode and does not show the live status of inventory of the production, the order said.

It further directed Naaptol to immediately discontinue any practices which create "artificial scarcity" of products, including showing that the product is available only today if it is going to be on sale within the next 30 days as well.

The company has been asked to clearly display on its channel or platform running a promotion that it is a pre-recorded episode.

The CCPA has also directed Naaptol to redress the complaints filed between May 2021 and January 2022 and submit a report within 15 days.

The National Consumer Helpline data indicates that 399 complaints were registered against Naaptol from June 2021 to Janary 25 this year, it added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :GSKGSK Consumer Health

First Published: Feb 10 2022 | 1:44 AM IST

Next Story